JB Capital’s Sanofi SNY Stock Holding History

JB Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,448	Closed	-$724K	–	262
2021 Q4	$724K	Buy	14,448 +288	+2%	+$14.2K	0.07%	138
2021 Q3	$683K	Buy	+14,160	New	+$720K	0.09%	141

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

JB Capital's SNY Position: Q1 2022 in Review

JB Capital sold out of Sanofi (SNY) in Q1 2022, closing a stake of 14,448 shares — an estimated $724K sold.

JB Capital first reported a position in SNY in Q3 2021 and held it in 2 quarters. The position peaked at $724K in Q4 2021. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

JB Capital reported no remaining Sanofi position as of Q1 2022 after selling out during the quarter.
JB Capital sold 14,448 Sanofi shares in Q1 2022, an estimated $724K.
JB Capital first reported a position in Sanofi in Q3 2021 and held it in 2 quarters.
JB Capital's Sanofi position peaked at $724K in Q4 2021.
623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on JB Capital's 13F filing for Q1 2022, filed 19 Apr 2022.